Bladder cancer is one of the most common cancers in the world and the most costly cancer to treat on a per‐patient basis.[1] Fibroblast growth factor receptors (FGFRs), a family of receptor tyrosine kinases (RTKs), regulate a variety of cellular processes. Here, NTRK1 is linked to cancer.